Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites

British Journal of Pharmacology

Volumn 135, Issue 4, 2002, Pages 891-900

  López Parra, Marta ^a   Clària, Joan ^a   Planagumà, Anna ^a   Titos, Esther ^a   Masferrer, Jaime L ^c   Woerner, B Mark ^c   Koki, Alane T ^c   Jiménez, Wladimiro ^a   Altuna, Rosario ^b   Arroyo, Vicente ^a   Rivera, Francisca ^a   Rodés, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Pharmacia Spain   (Spain)

^c Pharmacia Research and Development   (United States)

Author keywords

Experimental cirrhosis; Renal COX expression; Renal function; Selective COX inhibition

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; FUROSEMIDE; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASCITES; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT;

ANIMALS; ASCITES; BLOTTING, WESTERN; CARBON TETRACHLORIDE POISONING; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIURETICS; FUROSEMIDE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KIDNEY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES; WATER;

EID: 0036185248     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704528     Document Type: Article

References (43)

1. 2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
2. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis
3. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
4. Selective inhibition of cyclooxygenase-2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
5. 1 on renal function and plasma renin activity in alcoholic liver disease
6. Effects of specific inhibition on cyclooxygenase-2 on sodium balance, hemodynamics and vasoactive eicosanoids
7. Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats
8. High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
9. Role of eicosanoids in the control of renal function in severe hepatic disease
10. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
11. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge
12. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
13. 2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation
14. Prostaglandin synthase 2
15. Human cyclooxygenase-2 cDNA
16. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake
17. 2
18. Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
19. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
20. Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future
21. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
22. Arachidonic acid metabolites and the kidney
23. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
24. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis
25. Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kB
26. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
27. Nonsteroidal anti-inflammatory drugs; nonopioid analgesics; drugs used in gout
28. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis
29. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites
30. Sites and mechanisms of diuretics in the kidney
31. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
32. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
33. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet
34. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
35. Pharmacological analysis of cyclooxygenase-1 in inflammation
36. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
37. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells
38. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
39. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
40. Effects of celecoxib and naproxen on renal function in the elderly
41. Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro
42. Regulation of cyclooxygenase expression by dietary salt intake
43. Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease